During the past decade, UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group" #1 collaborator was "Amgen" with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group" are "Adenoid Cystic Carcinoma" (1 trials), "Adenoma, Pleomorphic" (1 trials), "Mixed Salivary Gland Tumor" (1 trials), "Salivary Gland Tumor, Mixed" (1 trials) and "Syringoma, Chondroid" (1 trials). Many other conditions were trialed in "UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Panitumumab" (1 trials), "Radiation" (1 trials) and "doxorubicin and bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".